Raphael Pharmaceutical Stock Price on October 8, 2024

RAPH Stock   0.26  0.00  0.00%   
If you're considering investing in Raphael OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Raphael Pharmaceutical stands at 0.26, as last reported on the 2nd of December, with the highest price reaching 0.26 and the lowest price hitting 0.26 during the day. Raphael Pharmaceutical maintains Sharpe Ratio (i.e., Efficiency) of -0.12, which implies the firm had a -0.12% return per unit of risk over the last 3 months. Raphael Pharmaceutical exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Raphael Pharmaceutical's Risk Adjusted Performance of (0.08), variance of 107.53, and Coefficient Of Variation of (812.40) to confirm the risk estimate we provide.
  
Raphael OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.124

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsRAPH

Estimated Market Risk

 10.45
  actual daily
93
93% of assets are less volatile

Expected Return

 -1.3
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.12
  actual daily
0
Most of other assets perform better
Based on monthly moving average Raphael Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Raphael Pharmaceutical by adding Raphael Pharmaceutical to a well-diversified portfolio.

Raphael Pharmaceutical Valuation on October 8, 2024

It is possible to determine the worth of Raphael Pharmaceutical on a given historical date. On October 8, 2024 Raphael was worth 1.65 at the beginning of the trading date compared to the closed value of 1.65. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Raphael Pharmaceutical otc stock. Still, in general, we apply an absolute valuation method to find Raphael Pharmaceutical's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Raphael Pharmaceutical where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Raphael Pharmaceutical's related companies.
 Open High Low Close Volume
  1.65    1.65    1.65    1.65    1.00  
10/08/2024
  1.65    1.65    1.65    1.65    1.00  
  1.65    1.65    1.65    1.65    1.00  
Backtest Raphael Pharmaceutical  |  Raphael Pharmaceutical History  |  Raphael Pharmaceutical Valuation   PreviousNext  
Open Value
1.65
1.65
Closing Value
33.00
Upside

Raphael Pharmaceutical Trading Date Momentum on October 8, 2024

On October 09 2024 Raphael Pharmaceutical was traded for  1.65  at the closing time. The top price for the day was 1.65  and the lowest listed price was  1.65 . There was no trading activity during the period 1.0. Lack of trading volume on October 9, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.00% .

Raphael Pharmaceutical Fundamentals Correlations and Trends

By evaluating Raphael Pharmaceutical's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Raphael Pharmaceutical's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Raphael financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Raphael Pharmaceutical OTC Stock history

Raphael Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Raphael is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Raphael Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Raphael Pharmaceutical stock prices may prove useful in developing a viable investing in Raphael Pharmaceutical

Raphael Pharmaceutical OTC Stock Technical Analysis

Raphael Pharmaceutical technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
A focus of Raphael Pharmaceutical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Raphael Pharmaceutical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Raphael Pharmaceutical Period Price Range

Low
December 2, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Raphael Pharmaceutical cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Raphael Pharmaceutical December 2, 2024 Market Strength

Market strength indicators help investors to evaluate how Raphael Pharmaceutical otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Raphael Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Raphael Pharmaceutical otc stock market strength indicators, traders can identify Raphael Pharmaceutical entry and exit signals to maximize returns

Raphael Pharmaceutical Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Raphael Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of Raphael OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Raphael to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Raphael OTC Stock analysis

When running Raphael Pharmaceutical's price analysis, check to measure Raphael Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Raphael Pharmaceutical is operating at the current time. Most of Raphael Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Raphael Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Raphael Pharmaceutical's price. Additionally, you may evaluate how the addition of Raphael Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance